Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...
Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...
According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.